| Study group (n = 6) | Control group (n = 50) | P | Effect size |
---|---|---|---|---|
Operative time (min) | 91 ± 34.8 (52–139) | 72.3 ± 14.2 (36–101) | 0.0147a | 0.703c |
ΔHb | 4.1 ± 1 (3–5.3) | 3.9 ± 0.4 (2.5–5.5) | 0.3467a | 0.262c |
HHS pre | 52.3 ± 7.6 (44–62) | 54.6 ± 4.8 (48–71) | 0.3035a | 0.361c |
HHS post | 88 ± 9.3 (75–100) | 96 ± 5.3 (83–100) | 0.0023a | 1.056c |
ΔHHS | 35.7 ± 11.3 (18–47) | 41.4 ± 5.1 (29–47) | 0.0352a | 0.650c |
Neurological complications (No. patients) | n = 4 (66.7%): 3 Femoral nerve lesions 2 LFCN lesions | n = 2 (4%): 2 LFCN lesions | 0.0006b | 48d |